Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01973036 · ClinicalTrials.gov registry record · NA
FOLCROM Trial: Foley Catheter in Rupture of Membranes
A NA study of Premature Rupture of Membranes, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 201
- Enrollment target
- 5
- Study locations
NCT01973036: Completed NA study of Premature Rupture of Membranes, sponsored by Geisinger Clinic.
NCT01973036 is a NA study of Premature Rupture of Membranes that has completed, run by Geisinger Clinic. The registered enrollment target is 201 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). The trial reports 5 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01973036, a NA study of Premature Rupture of Membranes, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 201 participants
- Enrollment target
- 5
- Study locations
Study Summary
Multicenter randomized clinical trial comparing oxytocin versus oxytocin and foley catheter for induction in women who present with premature rupture of membranes who are not in labor.
Primary Outcome
Time from induction (i.e., start time of Foley catheter or oxytocin) to delivery (hours), analyzed for all deliveries
Conditions Studied
Interventions
- DRUG Oxytocin
- DEVICE Foley Catheter
Study Locations (5)
Pennsylvania
- Lehigh Valley Hospital - Allentown
- Geisinger Medical Center - Danville
- Geisinger Wyoming Valley - Wilkes-Barre
Arizona
- Banner Good Samaritan Regional Medical Center - Phoenix
Delaware
- Christiana Care Health System CCHS - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2014-03 |
| Est. Completion | 2016-08 |
| Phase | NA |
What the finished NCT01973036 record still lists
NCT01973036 is an interventional study that assigns participants to a tested intervention. The registered 201 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Premature Rupture of Membranes appearing as the primary indexed condition, and to 2 interventions - of which Oxytocin is the first listed.
NCT01973036 lists 5 locations in 3 states (Pennsylvania, Arizona, Delaware).
Frequently Asked Questions
What is clinical trial NCT01973036 about?
NCT01973036 is a clinical study titled "FOLCROM Trial: Foley Catheter in Rupture of Membranes". Multicenter randomized clinical trial comparing oxytocin versus oxytocin and foley catheter for induction in women who present with premature rupture of membranes who are not in labor.
What is the current status of trial NCT01973036?
This trial is currently completed. It is a NA study. The enrollment target is 201 participants. The study started on 2014-03. Estimated completion is 2016-08.
What conditions does trial NCT01973036 study?
This clinical trial studies the following conditions: Premature Rupture of Membranes.
What interventions are being tested in trial NCT01973036?
The interventions under investigation include: Oxytocin (DRUG), Foley Catheter (DEVICE).
Who is sponsoring clinical trial NCT01973036?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01973036 being conducted?
This trial has 5 study locations across Arizona, Delaware, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01973036's enrollment target sits among peer trials
201 506th of 2000 higher than 1,495 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04422652 · 201 participants · Phase 2
Combination of Novel Therapies for CKD Comorbid Depression
- NCT05327114 · 201 participants · Phase 2
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- NCT06099769 · 201 participants · Phase 2
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
- NCT06274528 · 201 participants · Phase 2
DORA and LP in Alzheimer's Disease Biomarkers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia